PRESS ASSOCIATION: Targeting two faulty genes could be key in treating blood cancer – study
Press/Media: Research
Description
Targeting two faulty genes associated with a deadly form of blood cancer could help develop better treatments, scientists have said.
A new study, published in the journal Nature, suggests the mutated genes known as SRSF2 and IDH2 join forces to bring about acute myeloid leukaemia (AML) – an aggressive form of cancer in the white blood cells.
Media coverage
| Title | Targeting two faulty genes could be key in treating blood cancer – study |
|---|---|
| Media name/outlet | Press Association |
| Media type | Web |
| Country/Territory | United Kingdom |
| Date | 2/10/19 |
| Description | Targeting two faulty genes associated with a deadly form of blood cancer could help develop better treatments, scientists have said. A new study, published in the journal Nature, suggests the mutated genes known as SRSF2 and IDH2 join forces to bring about acute myeloid leukaemia (AML) – an aggressive form of cancer in the white blood cells. |
| URL | https://home.bt.com/news/science-news/targeting-two-faulty-genes-could-be-key-in-treating-blood-cancer-study-11364399534876 |
| Persons | Daniel Wiseman |